Skip to main content

Table 4 Hazard ratios for association of ADIPOQ SNP1, rs2241766 and rs2082940 with T2DM

From: Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study

SNP

Genotype

 

Entire DPS

 

Intervention group

 

Control group

  

N

HR (95% CI), pa/q

N

HR (95% CI), pb/q

N

HR (95% CI), pb/q

rs266729

CC

219

1

117

1

102

1

 

CG

240

0.695 (0.513-0.942), 0.019/0.203

121

0.733 (0.453-1.185), 0.205/0.616

119

0.661 (0. 444-0.985), 0.042/0.237

 

GG

48

0.615 (0.350-1.081), 0.091/0.330

21

0.400 (0.123-1.300), 0.128/0.616

27

0.743 (0.388-1.422), 0.370/0.818

 

CC

219

1

117

1

102

1

 

CG, GG

288

0.682 (0.510-0.912), 0.010/0.203

142

0.683 (0.428-1.090), 0.110/0.616

146

0.676 (0.464-0.985), 0.041/0.237

rs2241766

TT

460

1

231

1

229

1

 

TG

45

1.521 (0.944-2.452), 0.085/0.330

28

1.320 (0.625-2.786), 0.466/0.616

17

1.648 (0.881-3.083), 0.118/0.470

 

GG

2

5.448 (1.329-22.333), 0.019/0.203

0

-

2

4.993 (1.211-20.598), 0.026/0.237

 

TT

460

1

231

1

229

1

 

TG, GG

47

1.634 (1.035-2.579), 0.035/0.216

28

1.320 (0.625-2.786), 0.466/0.616

19

1.839 (1.028-3.289), 0.040/0.237

rs2082940

CC

466

1

233

1

233

1

 

CT

39

1.383 (0.812-2.357), 0.233/0.668

26

1.356 (0.642-2.862), 0.425/0.616

13

1.352 (0.627-1.917), 0.442/0.821

 

TT

2

5.368 (1.310-21.997), 0.020/0.203

0

-

2

4.885 (1.185-20.138), 0.028/0.237

 

CC

466

1

233

1

233

1

 

CT, TT

41

1.518 (0.918-2.512), 0.104/0.334

26

1.356 (0.642-2.862), 0.425/0.616

15

1.611 (0.813-3.196), 0.172/0.544

  1. aAdjusted for baseline BMI, WHR, fasting plasma glucose and study group
  2. bAdjusted for baseline BMI, WHR and fasting plasma glucose
  3. Correction for multiple hypothesis testing was performed with FDR, denoted as q-value.